1. Home
  2. PLAG vs IGC Comparison

PLAG vs IGC Comparison

Compare PLAG & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Green Holdings Corp.

PLAG

Planet Green Holdings Corp.

HOLD

Current Price

$2.45

Market Cap

25.6M

ML Signal

HOLD

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.28

Market Cap

28.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAG
IGC
Founded
1986
2005
Country
United States
United States
Employees
6
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.6M
28.5M
IPO Year
2007
2005

Fundamental Metrics

Financial Performance
Metric
PLAG
IGC
Price
$2.45
$0.28
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.25
AVG Volume (30 Days)
264.5K
323.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
32.56
59.09
EPS
N/A
N/A
Revenue
$6,729,937.00
$1,271,000.00
Revenue This Year
N/A
$3.54
Revenue Next Year
N/A
$15.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$0.24
52 Week High
$4.49
$0.50

Technical Indicators

Market Signals
Indicator
PLAG
IGC
Relative Strength Index (RSI) 44.01 58.61
Support Level $1.56 N/A
Resistance Level $3.07 $0.32
Average True Range (ATR) 0.55 0.02
MACD -0.16 0.00
Stochastic Oscillator 17.03 99.08

Price Performance

Historical Comparison
PLAG
IGC

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: